InvestoGain

Investogain Pty Limited
AFS Licence No. 334036

All correspondence to:
admin@delisted.com.au
or by mail to:
PO Box 400
Crows Nest NSW 1585

26 April 2025

Name:	ZENYTH THERAPEUTICS LIMITED (ZTL)
Date of Listing:	05 December 1996
Date of Delisting:	17 November 2006
Former Names:

Stock Exchange Status: (updated daily)

This entity was delisted from the Australian Securities Exchange on 17 November 2006.

Legal Status: (updated monthly)

To our knowledge this entity was the subject of a takeover or merger such that your securities were acquired for consideration in the form of cash or scrip. We have not therefore verified the current legal status of this entity. If you have questions about your shareholding, as we say elsewhere, they may be taken up here: https://www.delisted.com.au/TraceLostSharesLostMoney/index/.

Capital Gains Tax (CGT) Status: (updated at least quarterly)

To our knowledge this entity was the subject of a takeover or merger such that your securities were acquired for consideration in the form of cash or scrip. You will need to seek independent tax advice in relation to Capital Gains Tax or other tax matters but any other enquiries relating to your shareholding in the company should be followed up via our online form here: https://www.delisted.com.au/TraceLostSharesLostMoney/index/.

Updates, corrections, disagreements please email to admin@delisted.com.au

Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.

Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.

Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.

ZENYTH THERAPEUTICS LIMITED(ZTL)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

	FROM	TO
AMRAD CORPORATION LIMITED		07/12/2005

Shareholder links

Our website ranking of ZTL:

(1 out of 5)

COMPANY WEBSITE:

ZTL website

REGISTRY:

Yarra Falls, 452 Johnston Street, Abbotsford VIC 3067

Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 3 9473 2500
RegistryWebsite RegistryEmail

Company details

Address: 576 Swan Street , RICHMOND , VIC, AUSTRALIA, 3121
Tel: (03) 9208 4000 Fax: (03) 9208 4356

Date first listed: 05/12/1996
Company Secretary:
Sector: Pharmaceuticals & Biotechnology Industry Group: XHJ
Activities: Biotechnology company primarily focused on the development and commercialisation of antibody-based therapies in the areas of inflammation and cancer

News & Events

Expand this box to read and print

delisted following the lodgement of court orders approving the scheme of arrangement between the Company and CSL Limited	17/11/2006
we understand the consideration paid by CSL to Zenyth shareholders was $0.82 cash per Zenyth share - the cash consideration payable to Zenyth optionholders for each series of options (originally to be between $0.0100 and $0.5196 per Zenyth option, depending on the terms of the relevant Zenyth options) was increased to the higher of the value attributed to that series of options by the independent expert, Deloitte, and by Zenyth	17/11/2006
we understand that on or about this date the company undertook, proposed to undertake or was the subject of the following corporate action: - CSL to acquire 100% of the issued shares in Zenyth - this corporate event may appear elsewhere in this company record	17/11/2006
securities suspended from quotation at the request of the Company in accordance with listing rule 17.2, following the lodgement of court orders approving the scheme of arrangement between the Company and CSL Limited	31/10/2006
name changed from Amrad Corporation Limited	07/12/2005

ASX Announcements (courtesy of ASX)

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

Company Updates

Post your comments here

Please read our Terms before posting comments.

Click here for free access to this company's:
ASX, Legal & CGT Status

Directors' on-market share transactions (last 5)

Click here for the last 20 transactions all companies

Directors & Executives (current)

NAME	TITLE	DATE OF APPT
Ian Davis	Chairman
Andrew Nash	CEO
Alan Boyd	CFO
Silviu Itescu	Non Exec Director
Helen Cameron	Non Exec Director
James MacKenzie	Non Exec Director
Robyn Fry	General Counsel, Company Secretary

Date of first appointment, title may have changed.

Directors & Executives (former)

NAME	TITLE	DATE OF APPOINTMENT	DATE OF RESIGNATION

Date of first appointment, title may have changed.